Share
Journal Information
Most often read
17211
Position statement on the use of albumin in liver cirrhosisGraciela Castro-Narro, Carlos Moctezuma-Velázquez, Rene Male-Velázquez, Rafael Trejo-Estrada, Francisco Javier Bosques, Rosalba Moreno-Alcántar, Heriberto Rodríguez-Hernández, Aleida Bautista-Santos, ... Aldo Torre
Ann Hepatol. 2022;27:100708
17211
Open access
16153
Acid-base abnormalities and liver dysfunctionPeriklis Katopodis, Efthymios M. Pappas, Konstantinos P. Katopodis
Ann Hepatol. 2022;27:100675
16153
Open access
14959
NAFLD VS MAFLD. The evidence-based debate has come. Time to change?Diego García-Compeán, Alan Rafael Jiménez-Rodríguez
Ann Hepatol. 2022;27:100765
14959
Full text access
10096
From Child-Pugh to MELD score and beyond: Taking a walk down memory laneAndres Ruf, Melisa Dirchwolf, Richard B. Freeman
Ann Hepatol. 2022;27:100535
10096
Open access
9735
Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysisBabu Pappu Mohan, Sentia Iriana, Shahab Rasool Khan, Pradeep Yarra, Suresh Ponnada, Juan Fernando Gallegos-Orozco
Ann Hepatol. 2022;27:100741
9735
Full text access
8835
Clinical treatment of cholangiocarcinoma: an updated comprehensive reviewAlessandra Elvevi, Alice Laffusa, Miki Scaravaglio, Roberta Elisa Rossi, Raffaella Longarini, Anna Maria Stagno, Laura Cristoferi, Antonio Ciaccio, ... Sara Massironi
Ann Hepatol. 2022;27:100737
8835
Open access
8756
Current approaches to hepatic encephalopathyPaulina Vidal-Cevallos, Norberto C. Chávez-Tapia, Misael Uribe
Ann Hepatol. 2022;27:100757
8756
Full text access
7348
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and CPegah Golabi, James M. Paik, Katherine Eberly, Leyla de Avila, Saleh A. Alqahtani, Zobair M. Younossi
Ann Hepatol. 2022;27:100556
7348
Open access
6821
CAUSES OF DECOMPENSATION IN HOSPITALIZED CIRRHOTIC PATIENTSA.B. Moreno-Cobos, J.L. Pérez-Hernández, B.A. Enríquez-Constantino, M.Y Carmona-Castillo, E.J. Medina-Ávalos, C.L. Dorantes-Nava, M.F. Higuera-De la Tijera
Ann Hepatol. 2022;27 Supl 2:100589.12
6821
Open access
5743
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based studyOsama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
Ann Hepatol. 2022;27:100727
5743
Open access
5411
Management of COVID-19 patients with chronic liver diseases and liver transplantsXinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li
Ann Hepatol. 2022;27:100653
5411
Open access
4524
Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis BTania Queiroz Reuter, Michele Gomes-Gouvea, Samira Chuffi, Ulisses Horst Duque, José Americo Carvalho, Waltesia Perini, Marcello Moro Queiroz, Ingrid Marques Segal, ... João Renato Rebello Pinho
Ann Hepatol. 2022;27 Supl 1:100574
4524
Open access
3953
EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in BrazilMarlone Cunha-Silva, Fernando L. Ponte Neto, Priscila S. de Araújo, Lucas V. Pazinato, Raquel D. Greca, Tirzah M.L. Secundo, Marcello R. Imbrizi, Leonardo T. Monici, ... Daniel F. Mazo
Ann Hepatol. 2022;27:100543
3953
Open access
3740
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver diseaseToshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
Ann Hepatol. 2022;27:100699
3740
Open access
3723
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroidsSomayeh Shokri, Shahab Mahmoudvand
Ann Hepatol. 2022;27:100704
3723
Open access
3641
Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in MexicoLuis E. Gomez-Quiroz, Sonia Roman
Ann Hepatol. 2022;27 Supl 1:100649
3641
Open access
3591
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseasesMahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
Ann Hepatol. 2022;27:100702
3591
Open access
3360
Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shuntsQiao Ke, Zhiyong Wang, Xinhui Huang, Ling Li, Weimin Wu, Linbin Qiu, Yubin Jiao, Yixing Xie, ... Wuhua Guo
Ann Hepatol. 2022;27:100725
3360
Open access
3004
The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidenceFranco Trevisani, Edoardo G. Giannini
Ann Hepatol. 2022;27 Supl 1:100564
3004
Open access
2959
Analysis of the complete genome of HBV genotypes F and H found in Brazil and Mexico using the next generation sequencing methodPatrícia Oliveira Gionda, Michele Gomes-Gouvea, Fernanda de Mello Malta, Pedro Sebe, Ana Paula Moreira Salles, Rodrigo dos Santos Francisco, Alexis José-Abrego, Sonia Roman, ... João Renato Rebello Pinho
Ann Hepatol. 2022;27 Supl 1:100569
2959
Open access
Publish in
Annals of Hepatology
Affiliated societies
